Advertisement
Screener

Telomir Pharmaceuticals, Inc. (TELO) ROE

Telomir Pharmaceuticals, Inc. (TELO) ROE

  • 2026-06-30: ROE -116.74%.
  • 2026-03-31: ROE -185.89%.
  • 2025-12-31: ROE -176.10%.
  • 2025-09-30: ROE -161.20%.

Complete source-backed roe history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-116.74%
2026-03-31-185.89%
2025-12-31-176.10%
2025-09-30-161.20%
2025-06-30-3353.71%
2025-03-317732.81%
2024-12-31-2571.04%
2024-09-30-5194.05%
2024-06-30-1147.86%
2024-03-31-624.67%
2023-12-31-380.19%

Annual ROE

DateROE
2025-12-31-176.10%
2024-12-31-2571.04%
2023-12-31-380.19%
2022-12-3191.13%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Rallybio Corp (RLYB)United States$0.089B
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94